S3F-20863-35676
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 921 / CA
- Registered
- 2021-11-09
- Relationship
- Child or adolescent in my care
- Guardian
- VZK-11042-94019
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-07
Dose 1 — Pfizer-BioNTech
-
2021-11-09
Registered in v-safe
- 2021-11-09
- 2021-11-10
- 2021-11-12
- 2021-11-16
- 2021-11-22
- 2021-11-29
-
2021-11-30
Dose 2 — Pfizer-BioNTech
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-16
- 2021-12-21
- 2021-12-28
- 2022-01-11
-
2022-03-01
Survey response — 3 months, dose 2, dependentMedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Runny nose and sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-05-31
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-07 | Pfizer-BioNTech | No |
| 2 | 2021-11-30 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 2, dependent
Symptoms: Runny nose and sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release